SciPlay Gears Up for IPO
Digital games developer and publisher SciPlay has filed with the SEC regarding an initial public offering
All Work
Chris Lange
Merrimack Discontinues Cancer Study Amidst Layoffs
Merrimack Pharmaceuticals shares dipped on Friday after the firm announced that it would be discontinuing one of its cancer drugs as well as conducting layoffs.
Thursday’s Biggest Winners and Losers in the S&P 500
Thursday was a mixed day for the broad U.S. markets. In this case, it was the DJIA that was the only major exchange to make a meaningful gain on the day. Crude oil continued…
Is Office Depot Done After This Warning?
Office Depot shares took a dive on Thursday after the company announced preliminary estimated results for its fiscal first-quarter earnings.
PTSD Treatment Looked at for Fibromyalgia
Tonix Pharmaceuticals shares jumped on Monday after the firm announced the expansion of its late-stage PTSD treatment.
A Leaner Constellation Brands Looks Forward
Constellation Brands released better-than-expected fiscal fourth-quarter financial results before the markets opened on Thursday.
Why One Apple Analyst Is Cautious on Devices and App Store Growth
Apple has made some serious headway over the past month, begging the question whether the stock has run too much. One analyst thinks so.
How Nike Alone May Be Saving Shoe Retailers
Wedbush has a very bullish perspective on North American shoe companies considering the Nike product pipeline.
Is Dave & Buster’s Q4 Proving a Return to Its Popularity?
Dave & Buster’s Entertainment shares got a boost from better-than-expected fiscal fourth-quarter financial results.
Are Blue Apron Executive Changes Enough to Turn It Around?
The announcement of big changes to the Blue Apron executive team pushed shares of the food delivery service firm higher on Wednesday.
Drug Candidate Makes Big Strides in the Treatment of Parkinson’s Disease Cognitive Impairment
Aptinyx has announced positive preclinical data on its drug candidate demonstrating reversal of cognitive deficits in a nonhuman primate model of Parkinson’s disease.
The Search for Next-Generation Medical Cannabis for PTSD, Chronic Pain and Cancer
Agricultural engineering firm Evogene has announced the establishment of a new subsidiary to develop next-generation medical cannabis products.
Are GameStop Earnings Really That Bad?
GameStop shares tumbled early Wednesday after it released disappointing fiscal fourth-quarter financial results after the markets closed on Tuesday.
Tuesday’s Biggest Winners and Losers in the S&P 500
Tuesday was a mixed day for the broad U.S. markets. The Nasdaq was the only major exchange to make a meaningful gain on the day, while the DJIA and S&P 500 more or less…
What to Expect When GameStop Reports After the Close
GameStop is scheduled to release its fiscal fourth quarter financial results after the markets close on Tuesday.
What’s Next for Sangamo After This Hemophilia Study
Sangamo Therapeutics shares jumped on Tuesday after the company announced interim data from its midstage hemophilia trial in collaboration with Pfizer.
How Apyx Medical Was Crushed by the FDA
Apyx Medical shares dropped sharply on Tuesday after the company announced that it has voluntarily withdrawn its application for premarket notification 510(k) regulatory clearance of J-Plasma/Renuvion for use in dermal resurfacing procedures.
How Walgreens Tripped Up in Q2
Walgreens Boots Alliance released disappointing fiscal second-quarter financial results before the markets opened on Tuesday
Monday’s Biggest Winners and Losers in the S&P 500
Monday was positive day for the broad U.S. markets. Although it was April Fool’s Day, the S&P 500 and DJIA were not joking when they notched over a 1% gain each on the day.…
How Tilray Is Branching Out Its Business
Tilray shares dipped on Monday despite its announcement that it would be branching out and supporting two new clinical studies.